Literature DB >> 21178049

Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.

Eun Ja Lee1, Karel terBrugge, David Mikulis, Dae Seob Choi, Jong Myon Bae, Seon Kyu Lee, Soon Young Moon.   

Abstract

OBJECTIVE: In glioblastoma multiforme, the peritumoral region may be infiltrated with malignant cells in addition to vasogenic edema, whereas in a metastatic deposit, the peritumoral areas comprise predominantly vasogenic edema. The purpose of this study was to determine whether the minimum apparent diffusion coefficient (ADC) can be used to differentiate glioblastoma from solitary metastasis on the basis of cellularity levels in the enhancing tumor and in the peritumoral region.
MATERIALS AND METHODS: Seventy-three patients underwent conventional MRI and diffusion-weighted imaging (DWI) before undergoing treatment. The minimum ADC was measured in the enhancing tumor, peritumoral region, and contralateral normal white matter. To determine whether there was a statistical difference between metastasis and glioblastoma, we analyzed patient age and sex, minimum ADC value, and ADC ratio of the two groups. A receiver operating characteristic (ROC) curve analysis was used to determine the cutoff value of the minimum ADC that had the best combination of sensitivity and specificity for distinguishing between glioblastoma and metastasis.
RESULTS: The mean minimum ADC values and mean ADC ratios in the peritumoral regions of glioblastomas were significantly higher than those in metastases. However, the mean minimum ADC values and mean ADC ratios in enhancing tumors showed no statistically significant difference between the two groups. According to ROC curve analysis, a cutoff value of 1.302 × 10(-3) mm(2)/s for the minimum peritumoral ADC value generated the best combination of sensitivity (82.9%) and specificity (78.9%) for distinguishing between glioblastoma and metastasis.
CONCLUSION: Although the characteristics of solitary metastasis and glioblastoma multiforme may be similar on conventional MRI, DWI can offer diagnostic information to distinguish between the tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21178049     DOI: 10.2214/AJR.10.4752

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  45 in total

1.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

Review 2.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

Review 3.  Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Authors:  Shannon Puhalla; William Elmquist; David Freyer; Lawrence Kleinberg; Chris Adkins; Paul Lockman; John McGregor; Leslie Muldoon; Gary Nesbit; David Peereboom; Quentin Smith; Sara Walker; Edward Neuwelt
Journal:  Neuro Oncol       Date:  2015-05       Impact factor: 12.300

4.  Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.

Authors:  Hao Yu; Huiling Lou; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Zhongqing Huang; Yongxing Du; Chunxiu Jiang; Ling Ma; Jianbin Zhu; Wen He; Qihong Rui; Jianyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

5.  Differentiation between brain glioblastoma multiforme and solitary metastasis: qualitative and quantitative analysis based on routine MR imaging.

Authors:  X Z Chen; X M Yin; L Ai; Q Chen; S W Li; J P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-28       Impact factor: 3.825

6.  Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.

Authors:  Evangelia Tsolaki; Patricia Svolos; Evanthia Kousi; Eftychia Kapsalaki; Konstantinos Fountas; Kyriaki Theodorou; Ioannis Tsougos
Journal:  Int J Comput Assist Radiol Surg       Date:  2013-01-19       Impact factor: 2.924

7.  Utility of multiparametric 3-T MRI for glioma characterization.

Authors:  Bhaswati Roy; Rakesh K Gupta; Andrew A Maudsley; Rishi Awasthi; Sulaiman Sheriff; Meng Gu; Nuzhat Husain; Sudipta Mohakud; Sanjay Behari; Chandra M Pandey; Ram K S Rathore; Daniel M Spielman; Jeffry R Alger
Journal:  Neuroradiology       Date:  2013-02-02       Impact factor: 2.804

8.  Correlation of minimum apparent diffusion coefficient with maximum standardized uptake on fluorodeoxyglucose PET-CT in patients with rectal adenocarcinoma.

Authors:  Hale Çolakoğlu Er; Ayşe Erden; N Özlem Küçük; Ethem Geçim
Journal:  Diagn Interv Radiol       Date:  2014 Mar-Apr       Impact factor: 2.630

9.  Mean apparent diffusion coefficient values in defining radiotherapy planning target volumes in glioblastoma.

Authors:  Daniel Jeong; Christian Malalis; John A Arrington; Aaron S Field; Jung W Choi; Mehmet Kocak
Journal:  Quant Imaging Med Surg       Date:  2015-12

10.  Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; A D Schweitzer; A Prager; W Shi; Z Zhang; J Huse; A M P Omuro
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.